|
Jul 23
|
Here's Why Sutro Biopharma (NASDAQ:STRO) Must Use Its Cash Wisely
|
|
Jul 22
|
Sutro Biopharma Announces Research Collaboration with the FDA to Advance Regulatory Standards for Antibody Drug Conjugates
|
|
May 10
|
Sutro Biopharma First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
|
|
May 8
|
Sutro Biopharma, Inc. (STRO) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 8
|
Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights
|
|
Jan 22
|
We're Not Very Worried About Sutro Biopharma's (NASDAQ:STRO) Cash Burn Rate
|